-
. , . .2 , , .
2.
, [ 18 ]
●
●
●
●
● , ,
●
●
●
● (
[], , , , )
●
●
● -
●
●
●
●
(), . III , , , , -, [47].
(). - 15 , , , ( , ) 7,9% (, ) (3,9%). - [16].
( ), , ( , , , ), ( , - ), , (), , - , , , , , .
|
|
, , . , , . . ( , ).
II (1998 .) . III - - , . III , , , [47].
() , . , , ( , , , ), , , .
. , .
- : , , , , .
: , , , , . [38].
, , , , , .
, , , , H.pylori.
, (- , - , , .), (-), ( ). .
|
|
, , , ( 200-300 ) . .
H.pylori (, , , , , .). , .
, -, - , (, , ), .
.. (, , , , , .), .
, , .
, ( , .), , , , ( ) . .
(6 ), , . , , .
- , : () , ; B () , ; () , . , : 1 - , 2 , -, 3 , .
|
|
, [15, 54] ( 3).
. - , 2- , 2- [6, 36] ( 1). NNT (number needed to treat [ , , ]) 8 [47].
() , 2- . - 7 , 3241 , ( 33% 23% ). NNT 7 [35] ( 1).
, , () ( ), , , [35, 53, 55]. , , [47].
. - 13 , 3168 , , 36% (30%). NNT 17 [34]. ( 1). , .
, c H.pylori -4 (, 2010), ( ), [31]. , .
(< 10%) , , ( 2 ), ( 500 2 ) ( 1000 2 ). , :
1. ( ).
2. 7 10-14 .
3. 240 2 .
4. Saccharomyces boulardii ( 250 2 ).
5. .
(, ) (120 4 ) ( 2 ), (500 4 ), ( 500 3 ) 10 .
|
|
. , ( 2 ), ( 500 2 ) ( 1000 2 ). .
.
5 ( 2 ) ( 1000 2 ), 5 ( 2 ) ( 500 2 ) (500 2 ). ( 2 ), (1000 2 ), ( 500 2 ) ( 500 2 ). , , .
[5].
(, - ) . - 10 2- [6]. -, 14 , 1053 , , 61%, (41%). NNT 4 [33] ( 1).
(, ), .
. - 4 , 211 , [57].
, ( 25-30% ) - ( , , ), ( , , , , .), (, , , ), .
. .
- , 8 57%, 59% 64% , ( 50, 100 200 3 ), (41%) [19]. , [1,44].
- 8 , 2620 , , 1248 , . , , . [21].
: 5-1- (,), , (, , .), ( ), - , - (, ), , ., .
|
|
.
- 3 . (.. , ) [22] ( 1).
. , [45] ( 3).
. ( ) ( ) . - ( ) , , () 50 3 . , , 4 . , ( , ..). , , , , .
. [18].
.
, . . , [28, 54].
, , , [18].
, , , . , , , -, , , , - ( ) - ( ) .
- ( , , , ), , .
, , ( , ) - .
, .
1. .., .., .. ( ) - . 2009.- 13. .50- 54.
2. .. - . . . . . . ., 2008. 23 .
3. .. , , . . . . . - ., 2007. - 24 .
4.. .., .., .. . I, II -17 // . . . . . - 2005. - 3. - .48-51.
5. Helicobacter pylori // . . . ., . 2012. - 1. .87-89.
6. Allescher H.-D., Böckenhoff A., Knapp G. et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies // Scand.J.Gastroenterol. 2001. Vol.36. P.934-941.
7. Boekema P.J., van Dam E.F., Bots M.L. et al. Associations between use of alcohol, coffee and smoking and functional bowel symptoms in the general dutch population // DDW - New Orleans, 1998. Abstract A1070.
8. Buckley M., OMorain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia // Aliment.Pharmacol.Ther. 1995. Vol.9. Suppl.2. P.53-58.
9. Buonavolonta R., Goccorullo P., Boccia G. et al. Familial aggregation in children affected by functional gastrointestinal disorders // Gut. 2008. - Vol.57. Suppl.II. P. A3.
10. Caldarella M.P., Azpiroz F., Malagelada J.-R. Antro-fundic dysfunction in functional dyspepsia // Gastroenterology. 2003. Vol.124. P.1202-1229.
11. Camilleri M., Hasler W.I., Parkman H.P. et al. Measurement of gastrointestinal motility in the GI laboratory. - Gastroenterology. 1998. Vol.115. P.747-762.
12. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process First American Cancer Society award lecture on gastric cancer epidemiology and prevention // Cancer Res. 1992. Vol.52. P.7635-7640.
13. Corsetti M., Tack J. Mechanisms of functional dyspepsia and its relation to IBS // Irritable bowel syndrome. Diagnosis and treatment (Ed. Camilleri M., Spiller M.C.). W.B.Saunders. London. - 2002. P.117-126.
14. El-Omar E., Penman I., Ardill J.E. et al. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut. 1995. Vol.36. P.534-538.
15. Feinle-Bisset C., Vozzo R., Horowitz M., Talley N.J. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia // Amer.J.Gastroenterol. 2003. - Vol.99. P.170-181.
16. Ford F.C. Ching E., Moayyedi P. Meta-analysis of diagnostic tests for coeliac disease in dyspepsia // Aliment. Pharmacol. Ther. 2009. Vol. 30. P.28-36.
17. Führer M., Vogelsang M., Hammer J. A double blind, placebo controlled study of the oral capsaicin test in patients with functional dyspepsia // Gut. 2008. - Vol.57. - Suppl. II. P.A.38.
18. Holtmann G., Talley N.J. Clinicians manual on managing dyspepsia. Life Science Communications. London, 2000. 88 p.
19. Holtmann G., Talley N.J., T.Liebregts et al. A placebo-controlled trial of itopride in functional dyspepsia // N.Engl. J. Med. 2006. Vol.354. P. 832-840.
20. Holtmann G., Talley N.J. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful cooperation in research and practice? // Amer.J.Gastroenterol. 2006. Vol.101. P.593-595.
21. Huang X., Lv B., Zhang S. et al. Itopride therapy for functional dyspepsia: a meta-analysis // World J.Gastroenterol. 2012. Vol.18. P.7371-7377.
22. Jackson J.L., OMalley P.G., Tomkins G. et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis // Amer.J.Med. 2000. Vol.108. P.65-72.
23. Jones M.P., Ebert Ch.C. Bloating and somatosensory amplification in functional dyspepsia (FD) // Amer.J.Gastroenterol. 2003. Vol.98. P.63-64.
24. Kadota K., Takeshima F., Yoda A. et al. Effect of smoking cessation on gastric emptying in smokers // Gut. 2008. Vol.57. Suppl. II. P.A2.
25. Keohane J., Quigley E.M.M. Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis // World J.Gastoenterol. 2006. Vol.12. P.2672-2676.
26. Knill-Jones R.P. Geographical differences in the prevalence of dyspepsia // Scand. J.Gastroenterol. 1991 Vol. 26. - Suppl.182. - P.-17-24.
27. Koloski N.A., Talle N.J., Boyce Ph.M. Epidemiology and health care seeking in the functional GI disorders: a population-based study // Amer.J.Gastroenterol.- 2002.- Vol.97. P.2290-2299.
28. Lapidus L., Andersson S., Bengtsson G., Kilander A. Prognosis of dyspepsia in women a 24-year follow-up of a population sample // Gut. -2002. - Vol.34. - Suppl.II. P.A106.
29. Lin Z., Eaker E.Y., Sarosiek I., McCallum R. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia // Amer.J.Gastoenterol. 1999. Vol.94. P.2384-2389.
30. Locke G.R., Weaver A.L., Melton L.J., Talley N.J. Phsychological factors are linked to functional gastrointestinal disorders: a population based nasted case-control study. Amer.J.Gastroenterol. 2004. Vol.99. P.350-357.
31. Malfertheiner P., Megraud F., OMorain C. et al. Management of Helicobacter pylori infection the Maastricht IV Florence Consensus report // Gut. 2012. Vl.61. P.646-664.
32. McQuaid K.R. Dyspepsia // Sleisenger and Fordtrans gastrointestinal and liver disease (Ed.: M.Feldman et al.), 7th ed. Philadelphia-London-Toronto-Montreal-Sydney-Tokyo, 2002. P.102-118.
33. Moayyedi P., Soo S., Deeks J. et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia // Aliment, Pharmacol.Ther. 2003. Vol 17. P.1215-1227.
34. Moayyedi P., Deeks J., Talley N.J. et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepance between systematic reviews // Amer. J. Gastroenterol. - 2003. Vol.98. P.2621-2626.
35. Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis // Gastroenterology. 2004. Vol.127. P.1329-1337.
36. Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia // World J.Gastroenterol. 2006. Vol12. P.2694-2700.
37. Müller-Lissner S., Koelz H.R. Dyspepsiefibel. Berlin-Heidelberg-New York. 1991. 67 S.
38. Nimmuan C., Rabe-Hesketh S., Wessely S., Hotopf M. How many functional somatic syndromes? // J.Phychosom.Res. 2001.Vol.51. P.549-557.
39. Nyren O., Adami H.-O, Gustavsson S. et al. Social economic effects of non-ulcer dyspepsia // Scand.J.Gastroenterol.1985.Vol.20.- Suppl.109.P.41-45.
40. Peura D. Meeting expectations in FD: clinical and regulatory objectives. Clinicians viewpoint // Functional dyspepsia: current evidence and cutting edge outcomes. - Abstract book. Montreal, 2005. P.16-18
41. Samson M., Verhagen M.A., van Berge-Henegouwen G.P. et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999. Vol.116. P.515-520.
42. Sarnelli G., Caenepeel Ph., Geypens B. et al. Symptoms associated with impared gastric emptying of solids and liquids in functional dyspepsia // Amer.J.Gastroenterol. 2003. Vol.98. P.783-788.
43. Sarnelli G., De Giorgi F., Atteo E. et al. Frequency, symptom evolution and pathophysiological correlates in prospectively identified patients with postinfectious dyspepsia // DDW New Orleans, 2010. Abstract M2010.
44. Sawant P., Das H.S., Desai N et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // JAPI. 2004 Vol.52. - P.626-628.
45. Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for nonulcer duspepsia // Amer. J.Gastroenterol. 2004. Vol.99. P.1817-1822.
46. Stanghellini V., Tosetti C., Paternico A. et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia // Gastroenterology. 1996. Vol.110. P.1036-1042.
47. Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders // Gastroenterology. 2006. Vol.130. P. 1466-1479.
48. Tack J. Piessevaux H., Coulie B et al. Role of impaired gastric accommodation to a meal in functional dyspepsia // Gastroenterology. 1998. Vol.115. P.1346-1352.
49. Tack J., Caenepeel P., Fischler B. et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia // Gastroenterology. 2001. Vol.121. P.526-535
50. Talley N.J. and the working team for functional gastroduodenal disorders. Functional gastroduodenal disorders // In: The functional gastrointestinal disorders. Boston New York-Toronto-London, 1994. P.71-113.
51. Talley N.J., Helgeson S.L., Zinsmeister A.R. et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based-study // Gastroenterology. 1994.- Vol.107. P.1040-1049.
52. Talley N.J., Janssens L., Lauritsen K. et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 month follow up // Br.Med.J. 1999. Vol.318. P.833-837.
53. Talley N.J., Meineche-Schmidt V., Pare P. et al. Eficacy of omeprazole im functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) //Aliment. Pharnacol. Ther.1998.Vol.12.P.1055-1065.
54. Talley N.J., Stanghellini V., Heading R.C. et al. Functional gastroduodenal disorders // Rome II. The Functional Gastrointestinal Disorders (Ed D.A.Drossman).- 2. Edition. Allen Press. 2000. P.299-350.
55. Tominaga K., Suzuki H., Umegaki E. et al. Rabeprazole imprves the symptoms of functional dyspepsia a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study // DDW New Orleans, 2010. Abstract 383.
56. Van Lelyveld N., Scheffer R,., Mundt M., Samson M. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study // Amer.J.Gastroenterol. 2006. Vol.101. P.1845-1852.
57.Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., Talley N.J. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis // Am.J.Gastoenterol. 2001. Vol.96. P.689-696.
58. Warrwewijk C.J., Van Oijen M.G.H., Paloheimo L.I. et al. Influence of gastric mucosal status on successs of stepwise acid suppressive therapy for dyspepsia // Aliment.Pharmacol.Ther. 2009. Vol.30. P.82-89.
59. Wilhelmsen I., Haug T., Sipponen P., Berstad A. Helicobacter pylori in functional dyspepsia // Scand.J.Gastroenterol. 1994. Vol.29. P.522-527.